---
title: "Stocks in Play: Oncolytics Biotech Inc"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/235671119.md"
description: "01:45 PM EST - Oncolytics Biotech Inc : Has entered into a share purchase agreement with Alumni Capital LP, an institutional investor. This partnership will provide Oncolytics with a flexible source of funding, enabling the Company to progress pelareorep toward key clinical milestones and minimize dilution to create and sustain shareholder value. The SPA allows Oncolytics to be judicious and plan for the timing and amount of any equity sales, which will be critical as pelareorep's development continues. Oncolytics Biotech Inc sharesNC are trading up $0.19 at $0.89.Full Press Release:"
datetime: "2025-04-11T17:49:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235671119.md)
  - [en](https://longbridge.com/en/news/235671119.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235671119.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/235671119.md) | [English](https://longbridge.com/en/news/235671119.md)


# Stocks in Play: Oncolytics Biotech Inc

**01:45 PM EST - Oncolytics Biotech Inc :** Has entered into a share purchase agreement with Alumni Capital LP, an institutional investor. This partnership will provide Oncolytics with a flexible source of funding, enabling the Company to progress pelareorep toward key clinical milestones and minimize dilution to create and sustain shareholder value. The SPA allows Oncolytics to be judicious and plan for the timing and amount of any equity sales, which will be critical as pelareorep's development continues. Oncolytics Biotech Inc shares T.ONC are trading **up $0.19** at $0.89.  

_Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONC%3ACC&qmodStoryID=7936670508983147_

### 相關股票

- [Oncolytics Biotech (ONCY.US)](https://longbridge.com/zh-HK/quote/ONCY.US.md)

## 相關資訊與研究

- [Oncolytics Biotech Completes Domestication to Nevada with New Governance](https://longbridge.com/zh-HK/news/281401031.md)
- [Oncotelic Subsidiary Showcases Deciparticle Platform at BIO-Europe](https://longbridge.com/zh-HK/news/281062590.md)
- [Oncolytics to Present Pelareorep Translational Data at AACR 2026 Showing Immune Activation in Pancreatic and Breast Cancer](https://longbridge.com/zh-HK/news/279797186.md)
- [10:36 ET
			
			
				$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium](https://longbridge.com/zh-HK/news/274332234.md)
- [10:35 ET
			
			
				Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026](https://longbridge.com/zh-HK/news/272293777.md)